Radient Technologies Inc (RDDTF)
0.00
USD |
OTCM |
Nov 13, 16:00
Radient Technologies Max Drawdown (5Y): 100.00% for Sept. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 99.98% |
| January 31, 2024 | 99.98% |
| December 31, 2023 | 99.98% |
| November 30, 2023 | 99.98% |
| October 31, 2023 | 99.90% |
| September 30, 2023 | 99.90% |
| August 31, 2023 | 99.90% |
| July 31, 2023 | 99.90% |
| June 30, 2023 | 99.90% |
| May 31, 2023 | 99.83% |
| April 30, 2023 | 99.83% |
| March 31, 2023 | 99.83% |
| February 28, 2023 | 99.79% |
| January 31, 2023 | 99.79% |
| December 31, 2022 | 99.79% |
| November 30, 2022 | 99.79% |
| October 31, 2022 | 99.73% |
| September 30, 2022 | 99.57% |
| Date | Value |
|---|---|
| August 31, 2022 | 99.50% |
| July 31, 2022 | 99.02% |
| June 30, 2022 | 99.02% |
| May 31, 2022 | 98.88% |
| April 30, 2022 | 98.29% |
| March 31, 2022 | 98.22% |
| February 28, 2022 | 98.22% |
| January 31, 2022 | 98.22% |
| December 31, 2021 | 98.22% |
| November 30, 2021 | 97.87% |
| October 31, 2021 | 97.87% |
| September 30, 2021 | 97.29% |
| August 31, 2021 | 97.26% |
| July 31, 2021 | 96.67% |
| June 30, 2021 | 96.67% |
| May 31, 2021 | 96.67% |
| April 30, 2021 | 96.67% |
| March 31, 2021 | 96.67% |
| February 28, 2021 | 96.67% |
| January 31, 2021 | 96.67% |
| December 31, 2020 | 96.67% |
| November 30, 2020 | 96.48% |
| October 31, 2020 | 96.48% |
| September 30, 2020 | 96.48% |
| August 31, 2020 | 94.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
83.40%
Minimum
Nov 2019
100.00%
Maximum
Mar 2024
97.36%
Average
98.29%
Median
Apr 2022
Max Drawdown (5Y) Benchmarks
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
| Xenon Pharmaceuticals Inc | 54.01% |
| ESSA Pharma Inc | 98.68% |